The sponsor of a clinical trial, whose application has been submitted under the conditions provided for in 1 of Article 98 of the above-mentioned Regulation of 16 April 2014, may inform the designated personal protection committee within twenty-four hours that this application has already received a favourable opinion from another committee.
The designated committee may ask the Minister responsible for health for this file to be allocated to the committee that issued the first favourable opinion.